Related references
Note: Only part of the references are listed.Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis
H. S. Park et al.
ANNALS OF ONCOLOGY (2013)
Guidelines on CVD prevention: Confusing or complementary?
G. De Backer et al.
ATHEROSCLEROSIS (2013)
Statin use and risk of bladder cancer: a meta-analysis
Xiao-long Zhang et al.
CANCER CAUSES & CONTROL (2013)
Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Common cancer risk and statins: a population-based case-control study in a Chinese population
Henry W. C. Leung et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Statin use and the risk of esophageal cancer: a population-based case-control study
Te-Fu Chan et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
Kevin F. Erickson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Statins and the Risk of Lung Cancer: A Meta-Analysis
Min Tan et al.
PLOS ONE (2013)
Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study
Line D. Rasmussen et al.
PLOS ONE (2013)
Guidelines, position papers and critical reviews: differences and similarities
Zeljko Reiner
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis
Suetonia C. Palmer et al.
ANNALS OF INTERNAL MEDICINE (2012)
Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
Annie L. Culver et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Statins and Intracerebral Hemorrhage A Retrospective Cohort Study
Daniel G. Hackam et al.
ARCHIVES OF NEUROLOGY (2012)
Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project
Delphine De Smedt et al.
EUROPEAN HEART JOURNAL (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques
Faiez Zannad et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
Lipid-Modifying Therapies and Risk of Pancreatitis A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Meta-Analysis of Statin Effects in Women Versus Men
William J. Kostis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Statins for people at low risk of cardiovascular disease reply
Borislava Mihaylova et al.
LANCET (2012)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Paul M. Ridker et al.
LANCET (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class
Keith B. Hoffman et al.
PLOS ONE (2012)
Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis
M. Alberton et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2012)
Statin Therapy and the Risk of Intracerebral Hemorrhage A Meta-Analysis of 31 Randomized Controlled Trials
James S. McKinney et al.
STROKE (2012)
Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study
J. P. Sheppard et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Prevention of cardiovascular disease guided by total risk estimations - challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy
Faiez Zannad et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study
Jean Dallongeville et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
Bart S. Ferket et al.
PLOS MEDICINE (2012)
Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality
Ian Graham et al.
CURRENT CARDIOLOGY REPORTS (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
Statins for Cardiovascular Prevention According to Different Strategies A Cost Analysis
Marcia K. Ito et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2011)
Statins Are Associated With a Reduced Risk of Gastric Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Primary Prevention of Coronary Heart Disease With Statins It's Not About the Money
J. Sanford Schwartz
CIRCULATION (2011)
Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era
Lawrence D. Lazar et al.
CIRCULATION (2011)
The JUPITER Trial: Myth or Reality?
Ryan P. Morrissey et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Low-Dose Pravastatin and Age-Related Differences in Risk Factors for Cardiovascular Disease in Hypercholesterolaemic Japanese Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
Noriaki Nakaya et al.
DRUGS & AGING (2011)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
Zeljko Reiner
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2011)
Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women
A. Driscoll et al.
INTERNAL MEDICINE JOURNAL (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report
PEDIATRICS (2011)
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
J. P. Greving et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease From a 2005-2006 National Survey
Dusko Vulic et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
Coronary Mortality Declines in the US Between 1980 and 2000 Quantifying the Contributions from Primary and Secondary Prevention
Fiona Young et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
Statins for Primary Prevention in Older Adults: Who Is High Risk, Who Is Old, and What Denotes Primary Prevention?
Susan J. Zieman et al.
ANNALS OF INTERNAL MEDICINE (2010)
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
Robert J. Glynn et al.
ANNALS OF INTERNAL MEDICINE (2010)
Statins and All-Cause Mortality in High-Risk Primary Prevention A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
Kausik K. Ray et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey
Zeljko Reiner et al.
ATHEROSCLEROSIS (2010)
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials
Samia Mora et al.
CIRCULATION (2010)
Statin prescription in men and women at cardiovascular risk: to whom and when?
Jasper J. Brugts et al.
CURRENT OPINION IN CARDIOLOGY (2010)
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
Mario Petretta et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Association between Lowering Low-Density Lipoprotein Cholesterol with Pravastatin and Primary Prevention of Cardiovascular Disease in Mild to Moderate Hypercholesterolemic Japanese
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006
Jennifer G. Robinson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Public perceptions of cardiovascular risk factors in Croatia The PERCRO survey
Zeljko Reiner et al.
PREVENTIVE MEDICINE (2010)
Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement
Ned Calonge et al.
ANNALS OF INTERNAL MEDICINE (2009)
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Mark J. Pletcher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil N. Rajpathak et al.
DIABETES CARE (2009)
Statins for Secondary Cardiovascular Disease Prevention for Older Primary Care Patients
Richard Niska et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2009)
Lipid lowering for primary prevention
Salim Yusuf et al.
LANCET (2009)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco et al.
LANCET NEUROLOGY (2009)
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
Douglas C. A. Taylor et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. J. Brugts et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening? RESPONSE
Ned Calonge et al.
ANNALS OF INTERNAL MEDICINE (2009)
Statin therapy in stroke prevention: A meta-analysis involving 121,000 patients
Christopher O'Regan et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Statins and cancer: a meta-analysis of case-control studies
Marcia L. Taylor et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
J. D. Lundgren et al.
HIV MEDICINE (2008)
Statins, low-density lipoprotein cholesterol, and risk of cancer
Alawi A. Alsheikh-Ali et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The burden of hyperlipidaemia and diabetes in cardiovascular diseases
Marijan Merkler et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Ian Graham et al.
EUROPEAN HEART JOURNAL (2007)
Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities
Roberto Gnavi et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2007)
Statin treatment in children with familial hypercholesterolemia - The younger, the better
Jessica Rodenburg et al.
CIRCULATION (2007)
Cholesterol reduction yields clinical benefits: Meta-analysis including recent trials
A. Lawrence Gould et al.
CLINICAL THERAPEUTICS (2007)
Lipid levels and the risk of ischemic stroke in women
T. Kurth et al.
NEUROLOGY (2007)
Statins and the risk of lung, breast, and colorectal cancer in the elderly
Soko Setoguchi et al.
CIRCULATION (2007)
Risks associated with statin therapy - A systematic overview of randomized clinical trials
Amir Kashani et al.
CIRCULATION (2006)
Primary prevention of cardiovascular diseases with statin therapy - A meta-analysis of randomized controlled trials
Paaladinesh Thavendiranathan et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Haruo Nakamura et al.
LANCET (2006)
Family physician's knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: A National Research Network (NRN) survey
Charles B. Eaton et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2006)
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease
S Perreault et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
S Perreault et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Drug therapy in the heart transplant recipient - Part IV: Drug-drug interactions
RL Page et al.
CIRCULATION (2005)
Lipid-lowering therapy with statins in high-risk elderly patients - The treatment-risk paradox
DT Ko et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized controlled trial
A Wiegman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
S de Jongh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Low prevalence of lipid lowering drug use in older men with established coronary heart disease
PH Whincup et al.
HEART (2002)
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Efficacy and tolerability of long-term treatment with Lovastatin in women
M Clearfield et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2001)
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial
D Hunt et al.
ANNALS OF INTERNAL MEDICINE (2001)
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Additional perspectives on tolerability of long-term treatment with lovastatin
JR Downs et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Effects of lovastatin on cognitive function and psychological well-being
MF Muldoon et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
